Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation
Journal: Cancer Cell (2018)
Institution: Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143, USA
Research Areas: Melanoma
Cell Lines: Melanocytes (Engineered primary human melanocytes)
Summary: Utilizing precision genetic engineering and PHI’s HoloMonitor technology, scientists at University of California, San Francisco, have for the first time been able to monitor and map how mutations break down the genetic protection against skin cancer, allowing harmless moles to transform into invasive skin cancer.